The palladium-catalyzed cycloisomerization of acyclic bisdienes to
cyclized enedienes defines a novel
strategy for the stereoselective cyclization of certain unsymmetric
bisdiene substrates to form functionalized five-
and six-membered rings. The full details of our investigation into
this novel cycloisomerization, including our
observations on substrate requirements, stereoselectivity, the
influence of the catalyst precursor, and some mechanistic
insights drawn from deuterium labeling studies, are
discussed.
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
1997 ring closure reactions ring closure reactions O 0130
-065Catalytic Palladium-Mediated Bisdiene Carbocyclizations: Bisdiene to Enediene Cycloisomerizations.-Several examples are investigated in the Pd-catalyzed cycloisomerization of acyclic bisdienes to cyclized products defining a novel strategy for this stereoselective cyclization. Functionalized fiveand six-membered rings are generally formed in high yield and with high diastereoselectivity. The cyclization establishes the trans relative stereochemistry between the unsaturated side chains on the newly formed ring. In terms of labelling studies some mechanistic insights are discussed in order to assess the influence of the catalytic precursor, ligand and solvent. -(TAKACS, J. M.; CLEMENT, F.; ZHU, J.; CHANDRAMOULI, S. V.; GONG, X.; J. Am. Chem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.